Growth of the U.S. 503B Compounding Pharmacies Market Trends and Projections
The U.S. 503B compounding pharmacies market was valued at approximately $1.08 billion in 2023 and is expected to reach $2.25 billion by 2033. This growth represents a compound annual growth rate (CAGR) of 7.63% from 2024 to 2033. The increasing demand for 503B compounding pharmacies is driven by the growing emphasis on patient safety and the need to comply with stringent regulations.
Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5386